Evidence map›Paper›PMID 28368456›Full record

Trial reportThe Journal of infectious diseases2017

Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.

Niek B Achten, Pingsheng Wu, Louis Bont, Maarten O Blanken, Tebeb Gebretsadik, James D Chappell, Li Wang, Chang Yu, Emma K Larkin, Kecia N Carroll and 4 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 3 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 3 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. [Epidemiology, Mechanisms, and Clinical Challenges of Respiratory Syncytial Virus Co-infections in Children].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  8. Observational
  9. Article
  10. Review
  11. Article
  12. The impact of COVID-19 pandemic on the etiological spectrum of respiratory infections in children.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Niek B AchtenDepartment of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, the Netherlands.
Pingsheng WuDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Louis BontDepartment of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, the Netherlands.
Maarten O BlankenDepartment of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, the Netherlands.
Tebeb GebretsadikDepartment of Biostatistics.
James D ChappellDepartment of Pathology, Microbiology, and Immunology, and.
Li WangDepartment of Biostatistics.
Chang YuDepartment of Biostatistics.
Emma K LarkinDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Kecia N CarrollDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee.
Larry J AndersonDepartment of Pediatrics, Emory University, Atlanta, Georgia; and.
Martin L MooreDepartment of Pediatrics, Emory University, Atlanta, Georgia; and.
Chantel D SloanDepartment of Health Science, College of Life Sciences, Brigham Young University, Provo, Utah.
Tina V HartertDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Cancer Research And Biostatistics · USPulmonary and Allergy Associates · USUniversity Medical Center Utrecht · NLEmory University · USBipar · FRBrigham Young University · USVanderbilt University · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & AsthmaK24AI077930 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTERT, TINA V · 2008 to 2017
$1.6M
NCATS NIH HHS UL1 TR000445NIAID NIH HHS K24 AI077930
6 · The paper itself

Abstract

backgroundRespiratory syncytial virus (RSV) and human rhinovirus (HRV) are the most common viruses associated with acute respiratory tract infections in infancy. Viral interference is important in understanding respiratory viral circulation and the impact of vaccines.

methodsTo study viral interference, we evaluated cases of RSV and HRV codetection by polymerase chain reaction in 2 prospective birth cohort studies (the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure [INSPIRE] study and the Tennessee Children's Respiratory Initiative [TCRI]) and a double-blinded, randomized, controlled trial (MAKI), using adjusted multivariable regression analyses.

resultsAmong 3263 respiratory tract samples, 24.5% (798) and 37.3% (1216) were RSV and HRV positive, respectively. The odds of HRV infection were significantly lower in RSV-infected infants in all cohorts, with adjusted odds ratios of 0.30 (95% confidence interval [CI], .22-.40 in the INSPIRE study, 0.18 (95% CI, .11-.28) in the TCRI (adjusted for disease severity), and 0.34 (95% CI, .16-.72) in the MAKI trial. HRV infection was significantly more common among infants administered RSV immunoprophylaxis, compared with infants who did not receive immunoprophylaxis (OR, 1.65; 95% CI, 1.65-2.39).

conclusionsA negative association of RSV on HRV codetection was consistently observed across populations, seasons, disease severity, and geographical regions. Suppressing RSV infection by RSV immunoprophylaxis might increase the risk of having HRV infection.

Indexed as

Antiviral AgentsCoinfectionDisease SusceptibilityDouble-Blind MethodFemaleHumansInfantLength of StayLogistic ModelsMaleMultivariate AnalysisPalivizumabPicornaviridae InfectionsPolymerase Chain ReactionProspective StudiesRespiratory Syncytial Virus, HumanAntiviral AgentsPalivizumabHRVinfancy.Respiratory syncytial virusrhinovirusRSVRVviral interference

Identifiers

PMID28368456
PMCPMC5426371
OpenAlexW2602607363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.